QTRX
Quanterix Corp

1,102
Mkt Cap
$207.01M
Volume
419,747.00
52W High
$8.77
52W Low
$4.05
PE Ratio
-1.75
QTRX Fundamentals
Price
$4.41
Prev Close
$4.52
Open
$4.43
50D MA
$6.12
Beta
1.73
Avg. Volume
572,563.21
EPS (Annual)
-$2.51
P/B
0.70
Rev/Employee
$308,660.00
$190.19
Loading...
Loading...
News
all
press releases
Invenomic Capital Management LP Grows Stake in Quanterix Corporation $QTRX
Invenomic Capital Management LP boosted its stake in Quanterix Corporation (NASDAQ:QTRX - Free Report) by 21.7% during the third quarter, according to its most recent 13F filing with the Securities...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
William Blair Investment Management LLC Increases Holdings in Quanterix Corporation $QTRX
William Blair Investment Management LLC increased its stake in shares of Quanterix Corporation (NASDAQ:QTRX - Free Report) by 16.6% during the third quarter, according to its most recent filing with...
MarketBeat·16d ago
News Placeholder
Quanterix Q4 Earnings Call Highlights
Quanterix (NASDAQ:QTRX) reported fourth-quarter 2025 revenue of $43.9 million, up 25% from the prior year and up 7% sequentially, as the company cited a stronger-than-expected quarter driven in part...
MarketBeat·17d ago
News Placeholder
Quanterix Corporation (QTRX) Reports Q4 Loss, Beats Revenue Estimates
Quanterix (QTRX) delivered earnings and revenue surprises of -40.74% and +14.71%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·17d ago
News Placeholder
Quanterix (NASDAQ:QTRX) Issues Quarterly Earnings Results
Quanterix (NASDAQ:QTRX - Get Free Report) issued its quarterly earnings results on Monday. The company reported ($0.49) earnings per share for the quarter, missing the consensus estimate of ($0.27...
MarketBeat·17d ago
News Placeholder
Quanterix Earnings Report: Q4 Overview
read more...
Benzinga·17d ago
News Placeholder
Quanterix Releases Financial Results for the Fourth Quarter and Full Year 2025
Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced financial results for the fourth quarter and full year ended...
Business Wire·17d ago
News Placeholder
Lucent Diagnostics and Life Line Screening Partner to Bring Advanced Blood-Based Diagnostics to Communities Nationwide
Lucent Diagnostics, a brand of Quanterix Corporation (NASDAQ: QTRX), today announced a partnership with Life Line Screening (LLS), a national organization focused on identifying asymptomatic risks...
Business Wire·18d ago
News Placeholder
Curaleaf Holdings, Inc. (CURLF) Reports Q4 Loss, Tops Revenue Estimates
Curaleaf Holdings, Inc. (CURLF) delivered earnings and revenue surprises of +35.48% and +1.33%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·21d ago
News Placeholder
Quanterix to Participate in Upcoming Investor Conferences
Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that its executive leadership team will...
Business Wire·22d ago
<
1
2
...
>

Latest QTRX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.